MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

计划入组 1,783 人 · 首次发布于 2004 年 10 月 22 日

Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer

首次发布于 2002 年 12 月 17 日

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

计划入组 74 人 · 首次发布于 2006 年 2 月 1 日

MDPK-67b

MDX-1203

MDX-1185

MDX HEALTH

Morocco

INTO LONDON MDX STREET LLP

United Kingdom

Pixelgen Technologies Expands Protein Interactomics Platform to South Korea Through Strategic Distribution Partnership

PharmAla Biotech Unveils Phenesafe AI Platform to Accelerate MDXX Drug Discovery